Pyridine nucleotides
- (8)
- (1)
- (2)
- (1)
- (2)
- (3)
- (1)
- (7)
- (1)
- (1)
- (24)
- (1)
- (1)
- (2)
- (2)
- (1)
- (7)
- (5)
- (3)
- (3)
- (3)
- (1)
- (11)
- (1)
- (5)
Filtered Search Results
beta-Nicotinamide adenine dinucleotide, 97%
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
beta-Nicotinamide adenine dinucleotide hydrate, 98+%
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide Adenine Dinucleotide, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide Adenine Dinucleotide, Oxidized, Free Acid, 99%, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
b-Nicotinamide Adenine Dinucleotide, 95%, Spectrum™ Chemical
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N IUPAC Name: 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| CAS | 53-84-9 |
|---|---|
| Molecular Weight (g/mol) | 663.43 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| IUPAC Name | 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide adenine dinucleotide, oxidized Form, free acid, >98%, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide adenine dinucleotide phosphate, Cell Culture Reagent, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
β-Nicotinamide Adenine Dinucleotide, MP Biomedicals™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
beta-Nicotinamide Adenine Dinucleotide Hydrate, oxidized form 95.0+%, TCI America™
CAS: 53-84-9 Molecular Formula: C21H27N7O14P2 Molecular Weight (g/mol): 663.43 MDL Number: MFCD00150377 InChI Key: BAWFJGJZGIEFAR-WIWLTUSXNA-N Synonym: nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + PubChem CID: 15938971 ChEBI: CHEBI:57540 IUPAC Name: 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium SMILES: NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
| PubChem CID | 15938971 |
|---|---|
| CAS | 53-84-9 |
| Molecular Weight (g/mol) | 663.43 |
| ChEBI | CHEBI:57540 |
| MDL Number | MFCD00150377 |
| SMILES | NC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@H](COP([O-])(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O |
| Synonym | nicotinamide adenine dinucleotide,nad+,diphosphopyridine nucleotide,nad-oxidized,nicotinamide-adenine dinucleotide,dpn-ox,beta-nicotinamide adenine dinucleotide,dpn+,nad,nad + |
| IUPAC Name | 1-[(2R,3R,4S,5R)-5-{[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphonato)oxy]methyl}-3,4-dihydroxyoxolan-2-yl]-3-carbamoyl-1λ⁵-pyridin-1-ylium |
| InChI Key | BAWFJGJZGIEFAR-WIWLTUSXNA-N |
| Molecular Formula | C21H27N7O14P2 |
beta-Nicotinamide Adenine Dinucleotide Phosphate 83.0+%, TCI America™
CAS: 53-59-8 Molecular Formula: C21H30N7O18P3 Molecular Weight (g/mol): 761.423 MDL Number: MFCD00067537 InChI Key: ZKJOXOJMGXFSPF-QYZPTAICSA-N Synonym: Coenzyme II, beta-NADP, TPN, beta-Triphosphopyridine Nucleotide PubChem CID: 131675342 IUPAC Name: [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate;hydrate SMILES: C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)([O-])OCC3C(C(C(O3)N4C=NC5=C4N=CN=C5N)OP(=O)(O)O)O)O)O)C(=O)N.O
| PubChem CID | 131675342 |
|---|---|
| CAS | 53-59-8 |
| Molecular Weight (g/mol) | 761.423 |
| MDL Number | MFCD00067537 |
| SMILES | C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)([O-])OCC3C(C(C(O3)N4C=NC5=C4N=CN=C5N)OP(=O)(O)O)O)O)O)C(=O)N.O |
| Synonym | Coenzyme II, beta-NADP, TPN, beta-Triphosphopyridine Nucleotide |
| IUPAC Name | [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate;hydrate |
| InChI Key | ZKJOXOJMGXFSPF-QYZPTAICSA-N |
| Molecular Formula | C21H30N7O18P3 |
eMolecules 98-92-0 | Nicotinamide | Apollo Scientific | MFCD00006395 | 122.127 | C6H6N2O | 99.000 | NC(=O)c1cccnc1 | 100g | 562450877
Nicotinamide | Apollo Scientific | 98-92-0 | MFCD00006395 | 122.127 | C6H6N2O | 99.000 | NC(=O)c1cccnc1 | 100g | 562450877
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Medchemexpress LLC β-nicotinamide mononucleotide, reduced form disodium | 108347-85-9 | 99.6% | 380.20 g/mol | C11H15N2Na2O8P | 5 MG
Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More
β-Nicotinamide mononucleotide, reduced form disodium (NMNH) is the reduced disodium salt of nicotinamide mononucleotide supplied for research use in studies of NAD+ metabolism. It is provided as a powder with available analytical data for identity and purity and recommended cold, light-protected storage.
- Chemical formula: C11H15N2Na2O8P.
- Molecular weight: 380.20 g/mol.
- CAS number: 108347-85-9.
- Purity: 99.6% by HPLC.
- Recommended storage: protect from light, store under nitrogen at -20°C; in solution store at -80°C for long term.
- Analytical data available: COA, H NMR, C NMR, RP-HPLC, MS.
- Typical pack sizes: 1 mg, 5 mg, 10 mg.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Apexbio Technology LLC NICOTINAMIDE-N-OXIDE-100MG
Nicotinamide N-oxide (CAS No 1986-81-8) is a compound utilized in biomedical research particularly in the fields of enzymology and drug development It originates from the oxidation of nicotinamide a form of vitamin B3 The compound primarily targets pathways involved in cellular metabolism and oxidative stress responses Its mechanism of action includes modulating the activity of enzymes such as poly(ADP-ribose) polymerases impacting DNA repair processes and cellular energy homeostasis In vitro it exhibits activity in the nanomolar to low micromolar range making it suitable for detailed biochemical studies Typical applications include experiments in cell models and animal studies to investigate metabolic pathways assess oxidative stress and screen for potential drug candidates Experimental concentrations typically depend on the specific research design allowing for flexibility in various investigative contexts
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Selleck Chemical LLC NAD S2518-1g
NAD ( -DPN -NAD -Nicotinamide Adenine Dinucleotide nicotinamide adenine dinucleotide) is a coenzyme composed of ribosylnicotinamide 5 -diphosphate coupled to adenosine 5 -phosphate by pyrophosphate linkage
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More